Written by: Julian Chavarriaga, MD - Society of Urologic Oncology (SUO) Clinical Fellow at The University of Toronto, ...

Considering the existing gaps in the literature regarding patient radiation dose (RD) and its associated risks, a systematic review of the literature on RD was conducted, focusing on percutaneous ...

To determine the accuracy of voided urinary cytology (VUC) in predicting of non-muscle-invasive bladder cancer (NMIBC) risk stratification before surgery. We prospectively collected data from all ...

Amir Iravani, MD, and Evan Yu, MD Phillip Koo hosts a discussion on patient selection for radioligand therapy (RLT) in prostate cancer, featuring Amir Iravani and Evan Yu. The conversation delves into ...

Trends in Treatments for Erectile Dysfunction in Chile Between 2010 and 2020 with Special Focus on Penile Prostheses - Beyond the Abstract ...

EV-302/KEYNOTE-A39: Enfortumab Vedotin in Combination with Pembrolizumab (EV+P) Vs Chemotherapy in Previously Untreated Locally Advanced Metastatic Urothelial Carcinoma Thomas Powles, MD, MBBS, MRCP ...

William Oresick, MHA, CMD In a comprehensive discussion with Phillip Koo, Bill Oresick outlines the process of integrating a Lutetium-177-PSMA program into a large urology group practice. Mr. Oresick ...

A Modern Review of Penile Traction Monotherapy and Combination Therapy for the Treatment of Peyronie's Disease - Beyond the Abstract ...

EV-302/KEYNOTE-A39: Enfortumab Vedotin in Combination with Pembrolizumab (EV+P) Vs Chemotherapy in Previously Untreated Locally Advanced Metastatic Urothelial Carcinoma Thomas Powles, MD, MBBS, MRCP ...

Rahul Tendulkar presents the case of a 51-year-old male with elevated PSA and discussed important questions regarding combined modality therapy for lymph node-positive prostate cancer. Leslie Ballas ...

Role of Protease-Activated Receptor 2 in the development of lower urinary tract dysfunction - Beyond the Abstract ...

All patients had biopsy confirmed LG UTUC with cytology negative for high grade disease. At least one papillary low-grade tumor located superior to the ureteropelvic junction had to be present Size: 5 ...